Insider Trading Summary for Myriad Genetics Inc. (MYGN): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
07-Jun-24 4:53 PM View:	06-Jun-24 Grant 0	Phanstiel S. Louise Director		Myriad Genetics Inc. - MYGN	11% 145.07K to 160.77K	0	0	--	--	Show Txns Hide Txns

05-Dec-23 4:19 PM View:	01-Dec-23 Sale (Planned) ($572.84K)	Riggsbee Richard Bryan Chief Financial Officer		Myriad Genetics Inc. - MYGN	(9%) 321.81K to 291.81K	0	0	--	--	Show Txns Hide Txns

07-Jun-24 4:54 PM View:	06-Jun-24 Grant 0	Newcomer Lee Nisley Director		Myriad Genetics Inc. - MYGN	13% 72.85K to 82.34K	0	($156.86K) (9%)	--	$25.30	Show Txns Hide Txns

04-Sep-24 7:38 PM View:	03-Sep-24 Private Sale (Planned) ($1.29M)	Reitan Colleen F Director		Myriad Genetics Inc. - MYGN	(42%) 72.85K to 42.53K	0	0	--	--	Show Txns Hide Txns

04-Jun-24 5:57 PM View:	04-Jun-24 Market Sale (Planned) ($83.53K)	Spiegelman Daniel K Director		Myriad Genetics Inc. - MYGN	(19%) 40.49K to 32.92K	0	($167.01K) (19%)	--	$22.04 - $22.05	Show Txns Hide Txns

10-Jun-24 4:15 PM View:	06-Jun-24 Grant 0	Skovronsky Daniel Director		Myriad Genetics Inc. - MYGN	22% 70.31K to 86.01K	0	0	--	--	Show Txns Hide Txns

20-Aug-24 4:38 PM View:	19-Aug-24 Private Sale (Planned) ($210.08K)	Kumar Rashmi Director		Myriad Genetics Inc. - MYGN	12% 69.2K to 77.39K	0	0	--	--	Show Txns Hide Txns

10-Oct-24 4:31 PM View:	09-Oct-24 Payment of Exercise ($61.29K)	Haas Kevin Richard Chief Technology Officer		Myriad Genetics Inc. - MYGN	23% 105.68K to 129.58K	0	0	--	--	Show Txns Hide Txns

25-Mar-24 4:32 PM View:	22-Mar-24 Payment of Exercise ($32.05K)	Wong Pamela Chief Legal Officer		Myriad Genetics Inc. - MYGN	(6%) 69.01K to 65.0K	0	0	--	--	Show Txns Hide Txns

11-Oct-24 5:23 PM View:	11-Oct-24 Market Sale (Planned) ($343.95K)	Diaz Paul J President and CEO Director		Myriad Genetics Inc. - MYGN	(16%) 1.14M to 962.38K	0	($6.47M) (23%)	--	$22.93 - $26.72	Show Txns Hide Txns

10-Oct-24 4:36 PM View:	09-Oct-24 Payment of Exercise ($203.81K)	Verratti Mark Chief Commercial Officer		Myriad Genetics Inc. - MYGN	16% 249.74K to 289.28K	0	0	--	--	Show Txns Hide Txns

10-Oct-24 4:33 PM View:	09-Oct-24 Payment of Exercise ($11.02K)	Muzzey Dale Chief Scientific Officer		Myriad Genetics Inc. - MYGN	59% 67.78K to 107.56K	0	($54.96K) (3%)	--	$26.17	Show Txns Hide Txns

09-Sep-24 5:48 PM View:	09-Sep-24 Private Sale ($270.52K)	Dreismann Heiner Director		Myriad Genetics Inc. - MYGN	5% 115.95K to 121.65K	0	0	--	--	Show Txns Hide Txns

23-Sep-24 4:15 PM View:	21-Sep-24 Payment of Exercise ($26.64K)	Munk Natalie Chief Accounting Officer		Myriad Genetics Inc. - MYGN	10% 39.23K to 43.26K	0	0	--	--	Show Txns Hide Txns

07-Jun-24 4:53 PM View:	06-Jun-24 Grant 0	Bisaro Paul Director		Myriad Genetics Inc. - MYGN	64% 24.45K to 40.15K	0	0	--	--	Show Txns Hide Txns

23-Sep-24 4:17 PM View:	21-Sep-24 Payment of Exercise ($26.70K)	Ancona Margaret SVP, Chief of Staff		Myriad Genetics Inc. - MYGN	30% 60.27K to 78.4K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 4:45 PM View:	14-Mar-24 Grant 0	Solaiman Shereen Chief People Officer		Myriad Genetics Inc. - MYGN	252% 15.86K to 55.79K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 4:44 PM View:	14-Mar-24 Grant 0	Raha Samraat S. Chief Operating Officer		Myriad Genetics Inc. - MYGN	100% 0 to 300.85K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 4:44 PM View:	14-Mar-24 Grant 0	Leffler Scott J. Chief Financial Officer		Myriad Genetics Inc. - MYGN	100% 0 to 163.87K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 7:51 PM View:	03-Sep-24 Grant 0	Fox Jennifer Lynne Chief Legal Officer		Myriad Genetics Inc. - MYGN	100% 0 to 61.77K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	($6.85M)	$22.04 - $26.72

Myriad Genetics Inc. (MYGN)

Last Year

22-Nov-23 -- 21-Nov-24

Company Sentiment

Diagnostic Substances

Drugs

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades